pharmacological selectivity window

The selectivity window is the elbow room between the concentration that engages a drug's intended target and the concentration at which it starts disturbing something it should leave alone. Picture a radio dial where your station sits at one spot and a noisy neighbour station sits some distance away: the wider the gap, the more comfortably you can turn up the volume before the noise creeps in.

It is usually expressed as a ratio of two activity measures — for instance the off-target IC50 divided by the on-target IC50. A large window (say a hundredfold or more) means there is a broad band of concentrations where the desired action is strong and off-target activity is still negligible, so a clinical dose can sit safely inside it. A narrow window means the helpful and harmful activities switch on at nearly the same concentration, leaving little room to dose without trouble.

Widening this window is one of the central jobs of lead optimization. Chemists modify the molecule to push down off-target binding while keeping (or raising) on-target potency, and they confirm the result with counter-screens against likely off-targets. The selectivity window is closely related to the therapeutic window, but the two are distinct: the selectivity window compares activities at the molecular target level, whereas the therapeutic window compares whole-body benefit against whole-body harm, which also depends on pharmacokinetics.